In the present study, hand-to-hand bioelectrical impedance analysis (BIA), skinfold (SKF) thickness and height-weight (body mass index, BMI)-based equations and dual-energy X-ray absorptiometry (DEXA), as a criterion method, were compared with each other in the assessment of body fat percentage (BF%) in 17-18-year-old Estonian conscripts (n = 32). The Omron BF body fat monitor estimated that BF% was lower than that of the criterion method DEXA. The difference between DEXA and Omron BF 300 (III) was higher (1.1 +/- 3.0%; P = 0.04) and that between DEXA and Omron BF 306 lower (0.2 +/- 3.0%; P>0.05). Omron BF 300 (I) and (II) (series 8) had intermediate difference (0.9 +/- 3.0 and 0.9 +/- 3.0; P>0.05) when compared with DEXA. Three anthropometric equations estimated a higher BF% than cthat of DEXA. The Durnin & Womersley SKF equation BF% (1.0 +/- 2.4; P = 0.03) was higher than that of the DEXA. Deurenberg et al. and Gallagher et al. BMI-based equations overestimation yielded 0.9 +/- 3.7 and 0.6 +/- 3.8 BF% (P>0.05). From the anthropometric equations, only the Deurenberg et al. SKF equation slightly underestimated 0.5 +/- 3.4 BF% (P>0.05). DEXA-assessed BF% had highest correlation with SKF equations (r = 0.93), less so with BIA (r = 0.88-0.89) and lowest with BMI equation-assessed BF% (r = 0.81-0.84). All values were significant at P<0.001. We can conclude that the Omron BF 306 body fat monitor and the anthropometric Deurenberg et al. SKF equation yielded results close to the DEXA BF%.
No relation was observed between the antibiotic consumption rate and the resistance pattern of H. pylori to metronidazole, amoxicillin, erythromycin, tetracycline and ciprofloxacin during recent years among the in population.
Ultrasound elastography (USE) is a method to assess the stiffness of parenchymatous organs. Shear wave elastography (SWE) is considered to be the most suitable elastography method for the non-invasive kidney transplant (KTx) elasticity assessment. The aim of this study was to assess the implementability of SWE for the evaluation of kidney transplant elasticity measurement depending on the depth of an allograft, body mass index (BMI) and donor age. Secondly, to investigate the associations between SWE stiffness measurements and the clinical parameters. This cross-sectional prospective study involved consecutive 100 KTx patients were grouped according to time from transplantation and their BMI (in BMI<25 group the mean was 22.1±2.4, n=42 and in BMI≥25 group the mean BMI was 29.9±3.3, n=58). Mean estimated glomerular filtration rate was almost similar in both groups: <25 group 54.3 and ≥25 group 53.4 mL/min. Mean elastography results were found statistically different (p=0.006) BMI<25 (8.95±5.84 kPa) and BMI≥25 (5.95±3.16 kPa) groups. Significant correlation was found between SWE and the depth of the measurement (r=−0.4, p<0.05). The variations in USE stiffness values were smallest in patients group with lower BMI. In conclusion, we demonstrated that the non-invasive USE measurement stiffness result depends on a patient’s BMI, the depth of renal allograft and donor age.
The overall incidence of upper gastrointestinal disease, especially among young dyspeptic patients, was high compared with that observed in Western countries. The characteristics of dyspeptic patients, consulted in primary care, should be used for adaptation of the ESPCG guidelines to local needs.
Background: Guidelines for management of peptic ulcer patients after the treatment are largely directed to detection of H. pylori infection using only non-invasive tests. We compared the diagnostic value of non-invasive and endoscopy based H. pylori tests in a late post-treatment setting.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.